Country: Ireland
Language: English
Source: HMA (Heads of Medicines Agencies)
carprofen 100 mg
Norbrook Laboratories Limited
QM01AE91
Tablet
carprofen
Dogs
2011-06-16
Revised: June 2011 AN: 00149/2011 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Carprieve 100mg Tablets for Dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE INGREDIENTS: Carprofen 100 mg EXCIPIENTS: Tartrazine (E102) 1.2 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet A yellow circular tablet of 8 mm diameter, 100 embossed on one side and a single breakline on the other side. The tablets can be divided into equal halves. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In the dog: Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease. As a follow up to parenteral analgesia in the management of post operative pain. 4.3 CONTRAINDICATIONS Do not use in cats. Do not use in pregnant or lactating bitches. Do not use in puppies less than 4 months of age. Do not use in case of hypersensitivity to active substance or to any of the excipients. Revised: June 2011 AN: 00149/2011 Page 2 of 5 Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Refer to Sections 4.3 and 4.5. 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals Use in aged dogs may involve additional risk. If such a use Read the complete document